BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10997978)

  • 1. High cyclin-dependent kinase inhibitors in Bcl-2 and Bcl-xL-expressing CD34+-proliferating haematopoietic progenitors.
    Marone M; Pierelli L; Mozzetti S; Masciullo V; Bonanno G; Morosetti R; Rutella S; Battaglia A; Rumi C; Mancuso S; Leone G; Giordano A; Scambia G
    Br J Haematol; 2000 Sep; 110(3):654-62. PubMed ID: 10997978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lineage-specific regulation of cell cycle control gene expression during haematopoietic cell differentiation.
    Furukawa Y; Kikuchi J; Nakamura M; Iwase S; Yamada H; Matsuda M
    Br J Haematol; 2000 Sep; 110(3):663-73. PubMed ID: 10997979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
    Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional, phenotypic and molecular characterization of cytokine low-responding circulating CD34+ haemopoietic progenitors.
    Pierelli L; Scambia G; Fattorossi A; Bonanno G; Battaglia A; Rumi C; Marone M; Mozzetti S; Rutella S; Menichella G; Romeo V; Mancuso S; Leone G
    Br J Haematol; 1998 Sep; 102(5):1139-50. PubMed ID: 9753035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p21(Cip1/Waf1/Sdi1) and p27(Kip1) cyclin-dependent kinase inhibitors during human hematopoiesis.
    Taniguchi T; Endo H; Chikatsu N; Uchimaru K; Asano S; Fujita T; Nakahata T; Motokura T
    Blood; 1999 Jun; 93(12):4167-78. PubMed ID: 10361114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of bcl-2 and p27 in human primitive proliferating hematopoietic progenitors by autocrine TGF-beta1 is a cell cycle-independent effect and influences their hematopoietic potential.
    Pierelli L; Marone M; Bonanno G; Mozzetti S; Rutella S; Morosetti R; Rumi C; Mancuso S; Leone G; Scambia G
    Blood; 2000 May; 95(10):3001-9. PubMed ID: 10807762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible associations among expression of p14(ARF), p16(INK4a), p21(WAF1/CIP1), p27(KIP1), and p53 accumulation and the balance of apoptosis and cell proliferation in ovarian carcinomas.
    Saegusa M; Machida B D; Okayasu I
    Cancer; 2001 Sep; 92(5):1177-89. PubMed ID: 11571731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
    J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21Waf1/Cip1 and p27Kip1.
    Litvak DA; Evers BM; Hwang KO; Hellmich MR; Ko TC; Townsend CM
    Surgery; 1998 Aug; 124(2):161-9; discussion 169-70. PubMed ID: 9706134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
    Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
    Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-suppressor p53 is expressed in proliferating and newly formed neurons of the embryonic and postnatal rat brain: comparison with expression of the cell cycle regulators p21Waf1/Cip1, p27Kip1, p57Kip2, p16Ink4a, cyclin G1, and the proto-oncogene Bax.
    van Lookeren Campagne M; Gill R
    J Comp Neurol; 1998 Jul; 397(2):181-98. PubMed ID: 9658283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors.
    Fink JR; LeBien TW
    Exp Hematol; 2001 Apr; 29(4):490-8. PubMed ID: 11301189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of cyclin G1 and p21WAF1/CIP1 in neurons following transient forebrain ischemia: comparison with early DNA damage.
    van Lookeren Campagne M; Gill R
    J Neurosci Res; 1998 Aug; 53(3):279-96. PubMed ID: 9698156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
    Schreiber M; Muller WJ; Singh G; Graham FL
    Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.
    Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E
    Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdk-inhibitors and exit from quiescence in primitive haematopoietic cell subsets.
    Steinman R; Yaroslavskiy B; Goff JP; Alber SM; Watkins SC
    Br J Haematol; 2004 Feb; 124(3):358-65. PubMed ID: 14717785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
    Cipriano SC; Chen YQ
    Oncogene; 1998 Sep; 17(12):1549-56. PubMed ID: 9794232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation.
    Baldassarre G; Barone MV; Belletti B; Sandomenico C; Bruni P; Spiezia S; Boccia A; Vento MT; Romano A; Pepe S; Fusco A; Viglietto G
    Oncogene; 1999 Nov; 18(46):6241-51. PubMed ID: 10597222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell anti-apoptotic mechanisms in inflammatory myopathies.
    Vattemi G; Tonin P; Filosto M; Spagnolo M; Rizzuto N; Tomelleri G
    J Neuroimmunol; 2000 Nov; 111(1-2):146-51. PubMed ID: 11063832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.